ArticleJournal of clinical medicine2023

Longitudinal Assessment of Plasma Syndecan-1 Predicts 60-Day Mortality in Patients with COVID-19.

Quan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.